How should we manage empyema: Antibiotics alone, fibrinolytics, or primary video-assisted thoracoscopic surgery (VATS)?

Seminars in Respiratory and Critical Care Medicine

Volumn 28, Issue 3, 2007, Pages 322-332

  Cremonesini, David ^a   Thomson, Anne H ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

Empyema; Fibrinolysis; VATS

Indexed keywords

ALTEPLASE; ANTIBIOTIC AGENT; BUPIVACAINE; FIBRINOLYTIC AGENT; PLACEBO; RECOMBINANT DNA; STREPTOKINASE; UROKINASE;

ALLERGY; ANTIBIOTIC THERAPY; BLEEDING; CLINICAL TRIAL; EMPYEMA; ENDOSCOPIC SURGERY; FEVER; FIBRINOLYTIC THERAPY; HEALTH CARE COST; HUMAN; INJECTION SITE DISCOMFORT; LUNG RESECTION; NONHUMAN; PAIN; PRIORITY JOURNAL; REVIEW; THORACOSCOPY; THORACOTOMY; THORAX DRAINAGE; THORAX PAIN; VIDEORECORDING;

ANTI-BACTERIAL AGENTS; CHILD; DECISION MAKING; DRAINAGE; EMPYEMA, PLEURAL; FIBRINOLYTIC AGENTS; HEALTH CARE COSTS; HUMANS; THORACIC SURGERY, VIDEO-ASSISTED;

EID: 34250865095     PISSN: 10693424     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-981653     Document Type: Review

References (69)

1. Chin TW, Nussbaum E, Marks M. Bacterial pneumonia. In: BC Hillman, ed. Pediatric Respiratory Disease. Philadelphia: WB Saunders; 1993:271-281
2. Jones G, Steketee RW, Black RE, et al. How many child deaths can we prevent this year? Lancet 2003;362:65-71
3. Williams BG. Estimates of worldwide distribution of child deaths from acute respiratory tract infections. Lancet Infect Dis 2002;2:25-32
4. Hardie W, Bokulcic R, Garcia VF, Reising SF, Christie CD. Pneumococcal pleural empyemas in children. Clin Infect Dis 1996;22:1057-1063
5. Byington CL, Spencer LY, Johnson TA, et al. An epidemiological investigation of a sustained high rate of pediatric parapneumonic empyema: risk factors and microbiological associations. Clin Infect Dis 2002;34:434-440
6. Rees JH, Spencer DA, Parikh D, Weller P. Increase in incidence of childhood empyema in West Midlands, UK. Lancet 1997;349:402
7. Spencer DA, Iqbal SM, Hasan A, Hamilton L. Empyema thoracis is still increasing in UK children. BMJ 2006;332: 1333
8. Byington CL, Korgenski K, Daly J, Ampofo K, Pavia A, Mason EO. Impact of the pneumococcal conjugate vaccine on pneumococcal parapneumonic empyema. Pediatr Infect Dis J 2006;24:250-254
9. Ferguson AD, Prescott RJ, Selkon JB, Watson D, Swinburn CR. The clinical course and management of thoracic empyema. QJM 1996;89:285-289
10. Balfour-Lynn IM, Abrahamson E, Cohen G, et al. BTS guidelines for management of pleural infection in children. Thorax 2005;60(Suppl):1-21
11. Kroegel C, Anthony VB. Immunobiology of pleural inflammation: potential implications for pathogenesis, diagnosis and therapy. Eur Respir J 1997;10:2411-2418
12. Hamm H, Light RW. Parapneumonic effusion and empyema. Eur Respir J 1997;10:1150-1156
13. Chonmaitree T, Powell KR. Parapneumonic pleural effusion and empyema in children: review of a 19-year experience, 1962-1980. Clin Pediatr (Phila) 1983;22:414-419
14. Freij BJ, Kusmiesz H, Nelson JD, McCracken GH Jr. Parapneumonic effusions and empyema in hospitalized children: a retrospective review of 227 cases. Pediatr Infect Dis 1984;3:578-591
15. Alkrinawi S, Chernick V. Pleural infection in children. Semin Respir Infect 1996;11:148-154
16. Barnes NP, Hull J, Thomson AH. Medical management of parapneumonic pleural disease. Pediatr Pulmonol 2005;39: 127-134
17. Buckingham SC, King MD, Miller ML. Incidence and etiologies of complicated parapneumonic effusions in children, 1996 to 2001. Pediatr Infect Dis J 2003;22:499-504
18. Fletcher M, Leeming J, Cartwright K, Finn A. Childhood empyema: limited potential impact of 7-valent pneumococcal conjugate vaccine. Pediatr Infect Dis J 2006;25:559-560
19. Eastham KM, Freeman R, Kearns AM, et al. Clinical features, aetiology and outcome of empyema in children in the north east of England. Thorax 2004;59:522-525
20. Schultz KD, Fan LL, Pinsky J, et al. The changing face of pleural empyemas in children: epidemiology and management. Pediatrics 2004;113:1735-1740
21. Baranwal AK, Singh M, Marwaha RK, Kumar L. Empyema thoracis: a 10-year comparative review of hospitalised children from South Asia. Arch Dis Child 2003;88:1009-1014
22. King S, Thomson A. Radiological perspectives in empyema. Br Med Bull 2002;61:203-214
23. Donnelly LF, Klosterman LA. CT appearance of parapneumonic effusions in children: findings are not specific for empyema. AJR Am J Roentgenol 1997;169:179-182
24. Rehani MM, Berry M. Radiation doses in computed tomography. BMJ 2000;320:593-594
25. Stark DD, Federle MP, Goodman PC. Differentiating lung abscess and empyema; radiography and computed tomography. AJR Am J Roentgenol 1983;141:163-167
26. Muller NL. Imaging of the pleura. Radiology 1993;186:297-309
27. Coren ME, Ng V, Rubens M, Rosenthal M, Bush A. The value of ultrafast computed tomography in the investigation of pediatric chest disease. Pediatr Pulmonol 1998;26:389-395
28. Taryle DA, Good JT, Morgan EJ III, Reller LB, Sahn SA. Antibiotic concentrations in human parapneumonic effusions. J Antimicrob Chemother 1981;7:171-177
29. Umut S, Demir T, Akkan G, et al. Penetration of ciprofloxacin into pleural fluid. J Chemother 1993;5:110-112
30. Palacios GC, Gonzalez SN, Perez FL, Cuevas SF, Solorzano SF. Cefuroxime vs a dicloxacillin/chloramphenicol combination for the treatment of parapneumonic pleural effusion and empyema in children. Pulm Pharmacol Ther 2002;15:17-23
31. Avansino JR, Goldman B, Sawin RS, Flum DR. Primary operative versus nonoperative therapy for pediatric empyema: a meta-analysis. Pediatrics 2005;115:1652-1659
32. Jamal M, Reebye S, Zamakhshary M, Skarsgard ED, Blair GK. Can we predict the failure of thoracostomy tube drainage in the treatment of pediatric parapneumonic collections? J Pediatr Surg 2005;40:838-841
33. Ramnath RR, Heller RM, Ben-Ami T, et al. Implications of early sonographic evaluation of parapneumonic effusions in children with pneumonia. Pediatrics 1998;101:68-71
34. Rosen H, Nadkarni V, Theroux M, Padman R, Klein J. Intrapleural streptokinase as adjunctive treatment for persistent empyema in pediatric patients. Chest 1993;103:1190-1193
35. Stringel G, Hartman AR. Intrapleural instillation of urokinase in the treatment of loculated pleural effusions in children. J Pediatr Surg 1994;29:1539-1540
36. Khalil BA, Corbett PA, Jones MO, et al. Less is best? The impact of urokinase as the first line of management of empyema thoracis. Pediatr Surg Int 2006;23:129-133
37. Sonnappa S, Cohen G, Owens C, et al. Comparison of urokinase and video-assisted thoracoscopic surgery for treatment of childhood empyema. Am J Respir Crit Care Med 2006;174:221-227
38. Tasci S, Burghard A, Schafer H, Rabe C, Ewig S, Luderitz B. Long term outcome of intrapleural fibrinolytic therapy via small-bore catheter drainage in the management of complicated parapneumonic effusion and empyema: a case series. Med Klin (Munich) 2005;100:181-185
39. Ekingen G, Guvenc BH, Sozubir S, Tuzlaci A, Senel U. Fibrinolytic treatment of complicated pediatric thoracic empyemas with intrapleural streptokinase. Eur J Cardiothorac Surg 2004;26:503-507
40. Gates RL, Hogan M, Weinstein S, Area MJ. Drainage, fibrinolytics, or surgery: a comparison of treatment options in pediatric empyema. J Pediatr Surg 2004;39:1638-1642
41. Ulku R, Onen A, Onat S, Kilinc N, Ozcelik C. Intrapleural fibrinolytic treatment of multiloculated pediatric empyemas. Pediatr Surg Int 2004;20:520-524
42. Weinstein M, Restrepo R, Chait P, Connolly B, Temple M, Macarthur C. Effectiveness and safety of tissue plasminogen activator in the management of complicated parapneumonic effusions. Pediatrics 2004;113:e182-e185
43. Yao CT, Wu JM, Liu CC, Wu MH, Chuang HY, Wang JN. Treatment of complicated parapneumonic pleural effusion with intrapleural streptokinase in children. Chest 2004;125: 566-571
44. Singh M, Mathew JL, Chandra S, Katariya S, Kumar L. Randomized controlled trial of intrapleural streptokinase in empyema thoracis in children. Acta Paediatr 2004;93:1443-1445
45. Hawkins JA, Scaife ES, Hillman ND, Feola GP. Current treatment of pediatric empyema. Semin Thorac Cardiovasc Surg 2004;16:196-200
46. Barbato A, Panizzolo C, Monciotti C, Marcucci F, Stefanutti G, Gamba PG. Use of urokinase in childhood pleural empyema. Pediatr Pulmonol 2003;35:50-55
47. Hilliard TN, Henderson AJ, Langton Hewer SC. Management of parapneumonic effusion and empyema. Arch Dis Child 2003;88:915-917
48. Cochran JB, Tecklenburg FW, Turner RB. Intrapleural instillation of fibrinolytic agents for treatment of pleural empyema. Pediatr Crit Care Med 2003;4:39-43
49. Ozcelik C, Inci I, Nizam O, Onat S. Intrapleural fibrinolytic treatment of multiloculated postpneumonic pediatric empyemas. Ann Thorac Surg 2003;76:1849-1853
50. Wells RG, Havens PL. Intrapleural fibrinolysis for parapneumonic effusion and empyema in children. Radiology 2003;228:370-378
51. Thomson AH, Hull J, Kumar MR, Wallis C, Balfour-Lynn IM. Randomised trial of intrapleural urokinase in the treatment of childhood empyema. Thorax 2002;57:343-347
52. Kilic N, Celebi S, Gurpinar A, et al. Management of thoracic empyema in children. Pediatr Surg Int 2002;18:21-23
53. Light RW. A new classification of parapneumonic effusions and empyema. Chest 1995;108:299-301
54. Laisaar T, Pulleritis T. Effect of intrapleural streptokinase administration on anti-streptokinase antibody levels in patients with loculated pleural effusions. Chest 2003;123: 432-435
55. Davies CW, Lok S, Davies RJ. The systemic fibrinolytic activity of intrapleural streptokinase. Am J Respir Crit Care Med 1998;157:328-330
56. Blom D, van Aaldrenn WM, Alders JM, Hoekstra MO. Life-threatening haemothorax in a child following intrapleural administration of urokinase. Pediatr Pulmonol 2000; 30:493
57. Balci AE, Eren S, Ulku R, Eren MN. Management of multiloculated empyema thoracis in children: thoracotomy vs fibrinolytic treatment. Eur J Cardiothorac Surg 2002;22:595-598
58. Maskell NA, Davis CW, Nunn AJ, et al. UK controlled trial of intrapleural streptokinase for pleural infection. N Engl J Med 2005;352:865-874
59. Thomson AH. Pleural infection in children. International Pleural Newsletter 2006;4:7-8
60. Simpson G, Roomes D, Heron M. Effects of streptokinase and deoxyribonuclease on viscosity of human surgical and empyema pus. Chest 2000;117:1728-1733
61. Zhu Z, Hawthorne M, Guo Y, et al. Tissue plasminogen activator combined with human recombinant deoxyribonuclease is effective therapy for empyema in a rabbit model. Chest 2006;129:1577-1583
62. Simpson G, Roomes D, Reeves B. Successful treatment of empyema thoracis with human recombinant deoxyribonuclease. Thorax 2003;58:365-366
63. Pierrepoint MJ, Evans A, Morris SJ, Harrison SK, Doull IJ. Pigtail catheter drain in the treatment of empyema thoracis. Arch Dis Child 2002;87:331-332
64. Gates RL, Caniano DA, Hayes JR, Area MJ. Does VATS provide optimal treatment of empyema in children? A systematic review. J Pediatr Surg 2004;39: 381-386
65. Chang YT, Dai ZK, Lao EL, Chou SH, Huang MF. Thoracoscopic decortication: first-line therapy for pediatric empyema. Eur Surg Res 2005;37:18-21
66. Suchar AM, Zureikat AH, Glynn L, Statter MB, Lee J, Liu DC. Ready for the frontline: is early thoracoscopic decortication the new standard of care for advanced pneumonia with empyema? Am Surg 2006;72:688-692
67. Kurt BA, Winterhalter KM, Connors RH, Betz BW, Winters JW. Therapy of parapneumonic effusions in children: video-assisted thoracoscopic surgery versus conventional thoracostomy drainage. Pediatrics 2006;118:e547-e553
68. Cohen G, Hjortdal V, Ricci M, et al. Primary thoracoscopic treatment of empyema in children. J Thorac Cardiovasc Surg 2003;125:79-84
69. Meier AH, Smith B, Raghavan A, Ross RL, Harrison M, Skarsgard E. Rational treatment of empyema in children. Arch Surg 2000;135:907-912